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Background
Elevated plasma endotoxin levels are considered as indi-
cator of microbial translocation from the gut, and as a
potential cause of the systemic immune activation
observed in chronic HIV infection. Lipopolysaccharide
(LPS) effects on lymphocytes and macrophages have been
described to involve amongst other effects, downregula-
tion of CD4 and CCR5 and induction of CCL3/MIP-1α
and CCL4/MIP-1β secretion. This alteration in receptor
expression could potentially reduce HIV entry and may
thus pose a problem for assessing plasma antibody neu-
tralization in patient samples.
Methods
In the present study we evaluated the influence of LPS on
primary CD4 T cells cultivated under various in vitro con-
ditions. CD8-depleted PBMC and unseparated PBMC
were subjected to LPS from four different bacterial strains
(E. coli 0127:B8, E. coli 0127:B8, P. aeruginosa and S. enter-
ica serotype enteritidis). CD4 and coreceptor levels were
measured at various time points after treatment and the
infectability of the different cells compared using enve-
lope pseudotyped reporter virus.
Results
We observed no inhibitory influence of LPS on the infec-
tivity of PBMC by HIV env pseudotyped and MuLV env
pseudotyped virus over the entire range of LPS probed (1–
1000 pg/ml LPS). Equally, we observed no shifts in the
inhibitory capacity of neutralizing antibodies regardless
whether cells were pretreated with LPS, or upon simulta-
neous addition of LPS. Equally unaffected by LPS were
TZM-bl cells.
Conclusion
Our data indicate that HIV pseudotype infection and neu-
tralization assays on PBMC and TZM-bl cells are not
affected by trace sources of LPS. Plasma endotoxin at lev-
els reported in HIV infection will thus not interfere with
detection of neutralizing antibody activity in patient sera.
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